12:45 CET
PS6 - Pre-Congress Symposium 6 - Thyroid Committee / ESES: An Update on Differentiated Thyroid Cancer (DTC) - Overview of Management
Saturday, October 12, 13:00 - 16:00
Type of session: Pre-Congress Symposium
Chairpersons: S. Zerdoud (Toulouse/FR), A. Avram (Ann Arbor/US)

PS-39
13:00
Surgical Strategy at Initial Diagnosis
F. Sebag;
Assistance Publique Hôpitaux de Marseille, Endocrine and Metabolic Surgery, Marseille, FRANCE.
PS-40
13:25
Strategies and Concepts Regarding Post-Surgery Radioiodine Treatment of DTC
E. Hindie;
CHU hôpitaux de bordeaux Service Médecine Nucléaire, Bordeaux, FRANCE.
PS-41
13:50
Multiscale Prognostic Factors for the Management of DTC
L. Giovanella;
Imaging Institute of Southern Switzerland, Clinic for Nuclear Medicine, Bellinzona, SWITZERLAND.
PS-42
14:15
COFFEE BREAK
D. Discussion;
1
PS-43
14:45
Radioiodine Treatment for Metastatic DTC - How Much? How Many? How Often?
M. Luster;
University of Marburg, Department of Nuclear Medicine, Marburg, GERMANY.
PS-44
15:10
Redifferentiation of Radioiodine Refractory DTC
S. Leboulleux;
Nuclear Medicine and Endocrine Oncology, Gustave Roussy and Paris Saclay, Villejuif, FRANCE.
PS-45
15:35
Discussion
D. Discussion;
1
This website uses cookies. Learn more